SL
CLB icon

Salomon & Ludwin’s Core Laboratories CLB Stock Holding History

Salomon & Ludwin’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-347
Closed -$5.67K – 2122
2026
Q1 		$5.67K Hold
347
– – ﹤0.01% 1736
2025
Q4 		$6.29K Buy
+347
New +$5.17K ﹤0.01% 1690

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Salomon & Ludwin's CLB Position: Q2 2026 in Review

Salomon & Ludwin sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 347 shares — an estimated $5.67K sold.

Salomon & Ludwin first reported a position in CLB in Q4 2025 and held it in 2 quarters. The position peaked at $6.29K in Q4 2025. 187 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Salomon & Ludwin reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • Salomon & Ludwin sold 347 Core Laboratories shares in Q2 2026, an estimated $5.67K.
  • Salomon & Ludwin first reported a position in Core Laboratories in Q4 2025 and held it in 2 quarters.
  • Salomon & Ludwin's Core Laboratories position peaked at $6.29K in Q4 2025.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.